13 Best Growth Stocks Under $50 to Buy Now

Page 6 of 12

7. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Stock Price: $18.95

Number of Hedge Fund Holders: 57

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best growth stocks under $50 to buy now. On September 5, J.P. Morgan analyst Chris Schott maintained a Buy rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) and set a price target of $23.00.

On August 28, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced the FDA approval and U.S. launch of Generic Saxenda, the first-ever generic GLP-1 indicated for weight loss, targeting the rising demand for this category of therapies in the US market.

Management reported that the Liraglutide injection is indicated for “adults with obesity or overweight (excess weight) who also have weight-related medical problems, and pediatric patients (12-17 years) with a weight greater than 60 kg and obesity to help them lose weight and keep the weight off.”

Teva Pharmaceutical Industries Limited (NYSE:TEVA) develops, produces, and sells medicines. Its operations are divided into the US, Europe, and International Markets geographical segments.

Each business segment covers the entire product portfolio in that region, including specialty, generics, and over-the-counter (OTC) products.

Page 6 of 12